AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 9143747 — intervention group
Group type: EXPERIMENTAL
Intervention: CHO-E beverage
Number of subjects: 27
Study 9143747 — intervention group
Group type: EXPERIMENTAL
Intervention: Caloric intake
Number of subjects: 27
Study 9143747 — intervention group
Group type: COMPARATOR
Intervention: Placebo or water
Number of subjects: 27
Study 7910886 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin 500 mg followed by 250 mg daily for 7 days
Number of subjects: 19
Study 7910886 — intervention group
Group type: COMPARATOR
Intervention: Control group (no azithromycin)
Number of subjects: 19
Study 29241762 — intervention group
Group type: EXPERIMENTAL
Intervention: Eltrombopag
Number of subjects: 145
Study 29241762 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 145
Study 26840330 — intervention group
Group type: EXPERIMENTAL
Intervention: Guanidinoacetic Acid (GAA) 2.4 grams per day
Number of subjects: 21
Study 26840330 — intervention group
Group type: COMPARATOR
Intervention: Placebo (cellulose)
Number of subjects: 21
Study 26674497 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard therapy (oxycodone and pregabalin) plus magnesium oxide
Number of subjects: 150
Study 26674497 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy (oxycodone and pregabalin) plus placebo
Number of subjects: 150
Study 22930240 — intervention group
Group type: EXPERIMENTAL
Intervention: PTH(1-84) treatment over 24 months
Number of subjects: 781
Study 22930240 — intervention group
Group type: EXPERIMENTAL
Intervention: PTH(1-84) treatment with ≥80% adherence
Number of subjects: 781
Study 22930240 — intervention group
Group type: EXPERIMENTAL
Intervention: PTH(1-84) treatment
Number of subjects: 781
Study 22930240 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-discontinuation of PTH(1-84) treatment
Number of subjects: 781
Study 22930240 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherent group vs poorly adherent group
Number of subjects: 781
Study 20854662 — intervention group
Group type: EXPERIMENTAL
Intervention: Etanercept (25 mg s.c. biweekly)
Number of subjects: 20
Study 20854662 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 20
Study 19016147 — intervention group
Group type: EXPERIMENTAL
Intervention: Revascularization and stenting (group 1)
Number of subjects: 82
Study 19016147 — intervention group
Group type: COMPARATOR
Intervention: Medical treatment only (group 2)
Number of subjects: 82
Study 16621200 — intervention group
Group type: EXPERIMENTAL
Intervention: M. vaccae-derived protein (PVAC) 50 microg
Number of subjects: 165
Study 16621200 — intervention group
Group type: EXPERIMENTAL
Intervention: M. vaccae-derived protein (PVAC) 15 microg
Number of subjects: 165
Study 16621200 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 165
Study 16621200 — intervention group
Group type: EXPERIMENTAL
Intervention: M. vaccae-derived protein (PVAC)
Number of subjects: 165
Study 12537040 — intervention group
Group type: EXPERIMENTAL
Intervention: Family intervention for schizophrenia
Number of subjects: 79
Study 10781640 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.625 mg conjugated equine estrogen (n=15)
Number of subjects: 45
Study 10781640 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg simvastatin (n=15)
Number of subjects: 45
Study 10781640 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (n=15)
Number of subjects: 45
Study 8782136 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraarticular local anesthetic (bupivacaine 0.25%, 5 ml)
Number of subjects: 20
Study 8782136 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 1460156 — intervention group
Group type: EXPERIMENTAL
Intervention: Skills training counseling
Number of subjects: 126
Study 1460156 — intervention group
Group type: EXPERIMENTAL
Intervention: Support counseling
Number of subjects: 126
Study 1460156 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid smoking
Number of subjects: 126
Study 1460156 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine gum
Number of subjects: 126
Study 1460156 — intervention group
Group type: EXPERIMENTAL
Intervention: Skills training
Number of subjects: 126
Study 1460156 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reports of pretreatment craving
Number of subjects: 126
Study 2937131 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular medroxyprogesterone acetate (MPA) 500 mg/day for at least two months after the operation
Number of subjects: 165
Study 2937131 — intervention group
Group type: EXPERIMENTAL
Intervention: MPA 500 mg/3 times a week for one year
Number of subjects: 165
Study 2937131 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 165
Study 29846031 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacy-based intervention including medication review, regular dose dispensing, and counselling regarding medication use and symptoms of heart failure.
Number of subjects: 248
Study 29846031 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group).
Number of subjects: 248
Study 29846031 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacy-based intervention.
Number of subjects: 248
Study 26916877 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily Teriparatide (TPTD)
Number of subjects: 0
Study 26916877 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclic Teriparatide (TPTD)
Number of subjects: 0
Study 24866985 — intervention group
Group type: EXPERIMENTAL
Intervention: Fetal Alcohol Spectrum Disorder (FASD) knowledge survey
Number of subjects: 1035
Study 24866985 — intervention group
Group type: COMPARATOR
Intervention: Comparison with healthcare professionals
Number of subjects: 1035
Study 22802603 — intervention group
Group type: EXPERIMENTAL
Intervention: Phototherapy at 20 cm distance from the device
Number of subjects: 151
Study 22802603 — intervention group
Group type: EXPERIMENTAL
Intervention: Phototherapy at 29 cm distance from the device
Number of subjects: 151
Study 22802603 — intervention group
Group type: EXPERIMENTAL
Intervention: Phototherapy at 38 cm distance from the device
Number of subjects: 151
Study 22802603 — intervention group
Group type: EXPERIMENTAL
Intervention: Phototherapy at 47 cm distance from the device
Number of subjects: 151
Study 21034479 — intervention group
Group type: EXPERIMENTAL
Intervention: Pro-active multi-component nurse-led transitional care program (including a handover moment with a community care Care Nurse during hospital admission and five home visits after discharge)
Number of subjects: 674
Study 21034479 — intervention group
Group type: COMPARATOR
Intervention: Care as usual after discharge
Number of subjects: 674
Study 21034479 — intervention group
Group type: EXPERIMENTAL
Intervention: Pro-active multi-component nurse-led transitional care program
Number of subjects: 674
Study 18687376 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopamine D2 receptor (DRD2) 957C>T polymorphism
Number of subjects: 238
Study 18687376 — intervention group
Group type: COMPARATOR
Intervention: Control group (subjects without substance dependence)
Number of subjects: 238
Study 16162624 — intervention group
Group type: EXPERIMENTAL
Intervention: ACE inhibitors
Number of subjects: 20
Study 16162624 — intervention group
Group type: COMPARATOR
Intervention: No ACE inhibitors
Number of subjects: 20
Study 12236448 — intervention group
Group type: EXPERIMENTAL
Intervention: TTA lifting from 30 cm and knee height
Number of subjects: 8
Study 12236448 — intervention group
Group type: EXPERIMENTAL
Intervention: TFA lifting from knee and thigh height
Number of subjects: 8
Study 12236448 — intervention group
Group type: COMPARATOR
Intervention: Able-bodied controls lifting from all three heights
Number of subjects: 8
Study 12236448 — intervention group
Group type: EXPERIMENTAL
Intervention: TTA and TFA lifting mechanics
Number of subjects: 8
Study 12236448 — intervention group
Group type: EXPERIMENTAL
Intervention: TTA stability
Number of subjects: 8
Study 12236448 — intervention group
Group type: EXPERIMENTAL
Intervention: TFA stability
Number of subjects: 8
Study 9951573 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron pretreatment
Number of subjects: 20
Study 9951573 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 7759412 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg/kg of ketoprofen
Number of subjects: 12
Study 7759412 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo (control)
Number of subjects: 12
Study 2106841 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadrantectomy, axillary dissection, and radiotherapy (QUART)
Number of subjects: 1232
Study 232024 — intervention group
Group type: EXPERIMENTAL
Intervention: Saralasin
Number of subjects: 44
Study 232024 — intervention group
Group type: EXPERIMENTAL
Intervention: Converting enzyme inhibitors SQ 20881 and captopril
Number of subjects: 44
Study 232024 — intervention group
Group type: EXPERIMENTAL
Intervention: Saralasin, SQ 20881, and captopril
Number of subjects: 44
Study 232024 — intervention group
Group type: COMPARATOR
Intervention: Prior sodium depletion
Number of subjects: 44
Study 232024 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin blockade
Number of subjects: 44
Study 30290037 — intervention group
Group type: EXPERIMENTAL
Intervention: rTMS at 10 Hz (high frequency) and 1 Hz (low frequency) targeting the PCC and precuneus
Number of subjects: 20
Study 30290037 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 20
Study 30054634 — intervention group
Group type: EXPERIMENTAL
Intervention: Lay Health Worker intervention (6-month program)
Number of subjects: 213
Study 30054634 — intervention group
Group type: EXPERIMENTAL
Intervention: Lay Health Worker intervention (30 days before death)
Number of subjects: 213
Study 30054634 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 213
Study 26248655 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (InGaAlP laser, 650 nm, 100 mW, 2 J per point, applied from the first day of conditioning until D + 5)
Number of subjects: 35
Study 26248655 — intervention group
Group type: COMPARATOR
Intervention: Sham group (simulated laser treatment)
Number of subjects: 35
Study 26248655 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level laser therapy
Number of subjects: 35
Study 26248655 — intervention group
Group type: COMPARATOR
Intervention: Sham group
Number of subjects: 35
Study 24076059 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-FODMAP diet
Number of subjects: 30
Study 24076059 — intervention group
Group type: COMPARATOR
Intervention: Australian diet
Number of subjects: 30
Study 21586498 — intervention group
Group type: EXPERIMENTAL
Intervention: Music therapy for 30 min each morning for 11 days
Number of subjects: 24
Study 21586498 — intervention group
Group type: EXPERIMENTAL
Intervention: Music therapy
Number of subjects: 24
Study 21586498 — intervention group
Group type: COMPARATOR
Intervention: Control group (no music therapy)
Number of subjects: 24
Study 19823189 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention (TLP)
Number of subjects: 704
Study 19823189 — intervention group
Group type: COMPARATOR
Intervention: Metformin
Number of subjects: 704
Study 19823189 — intervention group
Group type: COMPARATOR
Intervention: Metformin plus rosiglitazone
Number of subjects: 704
Study 17023095 — intervention group
Group type: EXPERIMENTAL
Intervention: 9-valent conjugate pneumococcal vaccine
Number of subjects: 0
Study 15901744 — intervention group
Group type: EXPERIMENTAL
Intervention: Eniporide (2.5-400 mg)
Number of subjects: 457
Study 12612018 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrically induced blinking
Number of subjects: 4
Study 12612018 — intervention group
Group type: EXPERIMENTAL
Intervention: Spontaneous blinking
Number of subjects: 4
Study 12612018 — intervention group
Group type: EXPERIMENTAL
Intervention: Air puff induced blinking
Number of subjects: 4
Study 12612018 — intervention group
Group type: EXPERIMENTAL
Intervention: Eye position at 30 degrees above horizontal
Number of subjects: 4
Study 12612018 — intervention group
Group type: EXPERIMENTAL
Intervention: Eye position at 30 degrees below horizontal
Number of subjects: 4
Study 12612018 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated OO‐EMG
Number of subjects: 4
Study 12612018 — intervention group
Group type: EXPERIMENTAL
Intervention: Average blinking data
Number of subjects: 4
Study 10480777 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive therapy (IT)
Number of subjects: 25
Study 10480777 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy (CT)
Number of subjects: 25
Study 10480777 — intervention group
Group type: COMPARATOR
Intervention: Nondiabetic children
Number of subjects: 25
Study 8726832 — intervention group
Group type: EXPERIMENTAL
Intervention: Secretin
Number of subjects: 69
Study 8726832 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 69
Study 8726832 — intervention group
Group type: EXPERIMENTAL
Intervention: Secretin (in cirrhotic patients)
Number of subjects: 69
Study 8726832 — intervention group
Group type: COMPARATOR
Intervention: Placebo (in cirrhotic patients)
Number of subjects: 69
Study 1766125 — intervention group
Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate (ISDN) 20 micrograms.kg‐1
Number of subjects: 137
Study 1766125 — intervention group
Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate (ISDN) 40 micrograms.kg‐1
Number of subjects: 137
Study 1766125 — intervention group
Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate (ISDN)
Number of subjects: 137
Study 6351027 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythrityl tetranitrate (ETN) 5 mg
Number of subjects: 15
Study 6351027 — intervention group
Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate (ISDN) 5 mg
Number of subjects: 15
Study 6351027 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 31957168 — intervention group
Group type: EXPERIMENTAL
Intervention: SkinUp® Beauty Device
Number of subjects: 20
Study 31957168 — intervention group
Group type: COMPARATOR
Intervention: Corneometer® CM825
Number of subjects: 20
Study 31957168 — intervention group
Group type: EXPERIMENTAL
Intervention: SkinUp® Beauty Device and Corneometer® CM825
Number of subjects: 20
Study 30616791 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary radiotherapy (RT)
Number of subjects: 2754
Study 30616791 — intervention group
Group type: COMPARATOR
Intervention: Primary surgery (PS)
Number of subjects: 2754
Study 30616791 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary radiotherapy with concurrent chemotherapy (CRT)
Number of subjects: 2754
Study 30616791 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent chemotherapy with definitive RT
Number of subjects: 2754
Study 28471697 — intervention group
Group type: EXPERIMENTAL
Intervention: Pirfenidone 2,403 mg/d
Number of subjects: 1247
Study 28471697 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1247
Study 26402363 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-based care management intervention
Number of subjects: 136
Study 26402363 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 136
Study 23431120 — intervention group
Group type: EXPERIMENTAL
Intervention: Early enteral nutrition (EEN)
Number of subjects: 60
Study 23431120 — intervention group
Group type: COMPARATOR
Intervention: Delayed enteral nutrition (DEN)
Number of subjects: 60
Study 21177517 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance-based behavior therapy (ABBT)
Number of subjects: 16
Study 21177517 — intervention group
Group type: COMPARATOR
Intervention: Cognitive therapy (CT)
Number of subjects: 16
Study 20137430 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% levofloxacin (one-day group)
Number of subjects: 135
Study 20137430 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3% levofloxacin (one-day group)
Number of subjects: 135
Study 20137430 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3% tobramycin (one-day group)
Number of subjects: 135
Study 20137430 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% levofloxacin (three-day group)
Number of subjects: 135
Study 20137430 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3% levofloxacin (three-day group)
Number of subjects: 135
Study 20137430 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3% tobramycin (three-day group)
Number of subjects: 135
Study 20137430 — intervention group
Group type: EXPERIMENTAL
Intervention: PVI irrigation (one-day group)
Number of subjects: 135
Study 20137430 — intervention group
Group type: EXPERIMENTAL
Intervention: PVI irrigation (three-day group)
Number of subjects: 135
Study 20137430 — intervention group
Group type: EXPERIMENTAL
Intervention: Levofloxacin sensitivity (G(+)C)
Number of subjects: 135
Study 20137430 — intervention group
Group type: EXPERIMENTAL
Intervention: Levofloxacin sensitivity (G(-)B)
Number of subjects: 135
Study 17725542 — intervention group
Group type: EXPERIMENTAL
Intervention: ALA group (20 mg/kg body weight of 5-aminolevulinic acid)
Number of subjects: 0
Study 17725542 — intervention group
Group type: COMPARATOR
Intervention: White-light group
Number of subjects: 0
Study 17725542 — intervention group
Group type: EXPERIMENTAL
Intervention: ALA group
Number of subjects: 0
Study 15212625 — intervention group
Group type: EXPERIMENTAL
Intervention: Ziconotide
Number of subjects: 108
Study 15212625 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 108
Study 10975044 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-injection protocol for correcting postprandial blood glucose
Number of subjects: 0
Study 10975044 — intervention group
Group type: EXPERIMENTAL
Intervention: Postprandial blood glucose management
Number of subjects: 0
Study 10975044 — intervention group
Group type: EXPERIMENTAL
Intervention: Postprandial blood glucose
Number of subjects: 0
Study 10975044 — intervention group
Group type: EXPERIMENTAL
Intervention: OGTT 2 h blood glucose
Number of subjects: 0
Study 8869411 — intervention group
Group type: EXPERIMENTAL
Intervention: Isotonic saline (50 ml/kg for 1 h) in acute study
Number of subjects: 60
Study 8869411 — intervention group
Group type: EXPERIMENTAL
Intervention: High salt intake (260 mmol/day) in chronic study
Number of subjects: 60
Study 8869411 — intervention group
Group type: EXPERIMENTAL
Intervention: Low salt intake (30 mmol/day) in chronic study
Number of subjects: 60
Study 1948810 — intervention group
Group type: EXPERIMENTAL
Intervention: RU 28318 (160 mg)
Number of subjects: 80
Study 1948810 — intervention group
Group type: COMPARATOR
Intervention: Spironolactone (80 mg)
Number of subjects: 80
Study 6394759 — intervention group
Group type: EXPERIMENTAL
Intervention: naproxen
Number of subjects: 10
Study 6394759 — intervention group
Group type: EXPERIMENTAL
Intervention: sulindac
Number of subjects: 10
Study 31288186 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-LLETZ satisfactory colposcopy
Number of subjects: 601
Study 31288186 — intervention group
Group type: COMPARATOR
Intervention: Parity
Number of subjects: 601
Study 31288186 — intervention group
Group type: COMPARATOR
Intervention: Depth of LLETZ specimen
Number of subjects: 601
Study 31288186 — intervention group
Group type: COMPARATOR
Intervention: Age
Number of subjects: 601
Study 31288186 — intervention group
Group type: COMPARATOR
Intervention: Pre-LLETZ colposcopy results
Number of subjects: 601
Study 29403268 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 mg triamcinolone (2 mL) and 1 mL of 2% lidocaine
Number of subjects: 161
Study 29403268 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg triamcinolone (1 mL), 1 mL of 2% lidocaine, and 1 mL normal saline
Number of subjects: 161
Study 29403268 — intervention group
Group type: COMPARATOR
Intervention: 1 mL of 2% lidocaine and 2 mL normal saline
Number of subjects: 161
Study 26979830 — intervention group
Group type: EXPERIMENTAL
Intervention: Filorexant 2.5mg
Number of subjects: 324
Study 26979830 — intervention group
Group type: EXPERIMENTAL
Intervention: Filorexant 5mg
Number of subjects: 324
Study 26979830 — intervention group
Group type: EXPERIMENTAL
Intervention: Filorexant 10mg
Number of subjects: 324
Study 26979830 — intervention group
Group type: EXPERIMENTAL
Intervention: Filorexant 20mg
Number of subjects: 324
Study 26979830 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 324
Study 21833684 — intervention group
Group type: EXPERIMENTAL
Intervention: Shoulder manipulation and arthroscopic arthrolysis (Group A)
Number of subjects: 44
Study 21833684 — intervention group
Group type: COMPARATOR
Intervention: Glenohumeral steroid injections (Group B)
Number of subjects: 44
Study 20587725 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoglycemia (blood glucose 2.5 mmol/l) in nondiabetic participants
Number of subjects: 32
Study 20587725 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoglycemia (blood glucose 2.5 mmol/l) in type 1 diabetes
Number of subjects: 32
Study 18338960 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive screening for PTSD
Number of subjects: 164
Study 18338960 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive screening for depression
Number of subjects: 164
Study 18338960 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressant treatment
Number of subjects: 164
Study 18338960 — intervention group
Group type: EXPERIMENTAL
Intervention: PTSD screening
Number of subjects: 164
Study 18338960 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple regression analysis
Number of subjects: 164
Study 16122457 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel (n = 85)
Number of subjects: 919
Study 16122457 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel and aspirin (both)
Number of subjects: 919
Study 16122457 — intervention group
Group type: COMPARATOR
Intervention: Aspirin only (n = 598)
Number of subjects: 919
Study 16122457 — intervention group
Group type: COMPARATOR
Intervention: Neither medication (n = 236)
Number of subjects: 919
Study 16122457 — intervention group
Group type: COMPARATOR
Intervention: No clopidogrel (n = 834)
Number of subjects: 919
Study 12859607 — intervention group
Group type: EXPERIMENTAL
Intervention: Preseason strength training programme for the hamstring muscle group with eccentric overloading, performed 1-2 times a week for 10 weeks.
Number of subjects: 30
Study 12859607 — intervention group
Group type: COMPARATOR
Intervention: Control group (no additional specific hamstring training).
Number of subjects: 30
Study 12859607 — intervention group
Group type: EXPERIMENTAL
Intervention: Preseason strength training programme for the hamstring muscle group with eccentric overloading.
Number of subjects: 30
Study 10534038 — intervention group
Group type: EXPERIMENTAL
Intervention: Philadelphia collar on a hard wooden backboard
Number of subjects: 39